Menu
Not yet recruiting NCT07333768

EQUISOCK: New Antiequine

No phase Interventional Ankle (Ligaments); Instability (Old Injury) Ankle Equinus Ankle Dorsiflexion

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: EQUISOCK, Other ankle orthosis.
Who it may be relevant to
Registry conditions: Ankle (Ligaments); Instability (Old Injury), Ankle Equinus, Ankle Dorsiflexion. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

EQUISOCK: New Antiequine for Ankle

Overview

The goal of this experimental study is to test the feasibility and validity of a new orthosis in patients with ankle lesions (external popliteal sciatic nerve or nerve injuries resulting in loss of ankle dorsiflexion) of both sexes and all ages. The main question it aims to answer is:Is the new orthosis a support for ankle stability??Does the new orthosis improve ankle function and patients' quality of life??The control group will be the subjects themselves when wearing their conventional ankle orthosis or without it. Participants must wear the new ankle orthosis for at least one month to assess the effectiveness of the orthosis and evaluate any changes that have occurred in the ankle joint and muscles.

Interventions

  • Device EQUISOCK
    Participants must wear the new ankle orthosis during assessments and in their daily lives for at least one month, which is the duration of the study.
  • Device Other ankle orthosis
    Participants must wear the conventional ankle orthosis and without orthosis, during assessments and before wearing the new one

Primary outcome measures

  • Device Feasibility [Time frame: Baseline and up to 4 weeks]
Secondary outcome measures (3)
  • Ankle function with virtual reality [Time frame: Baseline and up to 4 weeks]
  • Range of motion with Gyko device [Time frame: Baseline and up to 4 weeks]
  • Footprint with a pressure platform [Time frame: Baseline and up to 4 weeks]

Eligibility criteria

Inclusion criteria

  • patients with chronic ankle injuries
  • patients with external popliteal sciatic nerve lesion or nerve injuries resulting in loss of ankle dorsiflexion
  • patients who have already been prescribed an orthosis
  • patients of all ages

Exclusion criteria

  • inability to stand actively and stably
  • inability to walk unaided
  • inability to follow instructions

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Crossover
Masking
Double blind
Primary purpose
Device feasibility

Study locations

Spain · 1 center
  • University of Salamanca — Salamanca

Identifiers

NCT: NCT07333768 · EQUISOCK2026 · University of Salamanca

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗